Nature：中国将大力改革科研资助体系，“973”和“863”将被停止
今天《自然》消息：
2017年973和863将被停止，并整合国家自然科学基金，重新设计5种不同类型的科研资助体系，科研部统一管理。这将是国家对竞争性科研计划最大的一次改革。
1. the National Natural Science Foundation (which currently distributes many of the small-scale competitive grants);
2. national science and technology major projects;
3. key national research and development programmes;
4. a special fund to guide technological innovation;
5. and special projects for developing human resources and infrastructure.
These five will be managed under a new science and technology agency that will unify planning and assessment of scientific projects.
On 20 October, the Chinese government announced the passage of a reform plan that will fundamentally reshape research in the country.
By 2017, the main competitive government funding initiatives will be eliminated. This includes the ’863′ and ’973′ programmes, two channels for large grants that have been at the heart of modern China’s development of science and technology infrastructure since being established in 1986 and 1997, respectively.
The government announcement noted that wastefulness and fragmented management has led to overlaps and inefficient use of funds for science and technology, and the need for a unified platform for distributing grants. As new funding programmes have been added over the years, competitive funding has become divided among some 100 competitive schemes overseen by about 30 different governmental departments.
Although efforts to reorganize science in China are already underway, the latest reform will be comprehensive. Science and technology spending by the central government was 77.4 billion yuan renminbi (US$12.6 billion) in 2006 but jumped to 236 billion yuan renminbi in 2013, 11.6% of the central government’s direct public expenditure. Some 60% of this is competitive funding, and subject to change under under the new reforms. To maintain stability, the overhaul will not affect the remaining 40%, which covers operation costs for research institutes and key state laboratories.
作者：孙学军 来源：科学网
微信公众号：中国生物技术信息网截止到2014年9月30日Top30文章列表新鲜出炉！回复标题后括号中的期号可阅读该篇文章，如“20140518”。
回复“埃博拉”可阅读埃博拉相关专题人气文章。
回复"转基因"可阅读转基因相关专题人气文章。
回复"大数据"可阅读大数据相关专题人气文章。
回复“癌细胞”可阅读癌细胞、癌症相关专题人气文章。
回复“糖尿病”可阅读糖尿病相关专题人气文章。
回复“测序”可阅读测序相关专题人气文章。
回复“免疫”可阅读免疫相关专题人气文章。
1、中式体检让美国医生瞠目结舌(20140518)
2、施一公组：六年，一场“聚光灯”下的负重跑（20140704）
3、“科研过劳症”离你并不遥远(20140822）
4、25位诺奖获得者联名支持转基因(20140802)
5、一篇Ebola论文之沉重：六名作者去世(20140831)
6、哈佛大学遗传学家：转基因食品安全之我见(20140508)
7、Nature关注：中国科学界面临重大改革（20140924）
8、施一公、王晓东院士：基础研究有什么用(20140505)
9、中国人为什么反转基因(20140810)
10、揭秘：人类为何越来越易过敏？（20140918）
11、转基因基础解惑（20140622）
12、饶毅：扒铁路保龙脉与反转基因保龙种(20140808)
13、2014年度国家自然科学基金分析(20140821)
14、每日步行2公里癌症风险减半（20140913）
15、Nature：戳穿甜味剂的健康谎言（20140918）
16、图解常用肿瘤标志物(20140515)
17、《柳叶刀》上的中国(20140808)
18、汤森路透发布2014年最新SCI杂志影响因子（20140730）
19、睡眠，世界上最有效的健康仙丹（20140926）
20、世界顶级癌症专家教你怎样活得更久（20140920）
21、人为何会得癌症？（20140921）
22、如何拉出健康的便便？(20140830)
23、肠道可能在撒谎(20140831)
24、施一公：八面玲珑的人难做科学家？(20140811)
25、11种蔬菜千万别生吃（20140706）
26、体内微生物平衡对健康至关重要（20140722）
27、令人恐怖的埃博拉病毒(20140801)
28、谷歌学术发布2014年度期刊排名（20140628）
29、遗传学10大奇异事实（20140529）
30、各国食物有多长肉？英国Evoke.Le发布排行榜(20140816)